Sweden · Delayed Price · Currency is SEK Physitrack Statistics
Total Valuation
Physitrack has a market cap or net worth of SEK 163.42 million. The enterprise value is 206.30 million.
| Market Cap | 163.42M |
| Enterprise Value | 206.30M |
Important Dates
The next confirmed earnings date is Tuesday, October 20, 2026.
| Earnings Date | Oct 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Physitrack has 16.26 million shares outstanding.
| Current Share Class | 16.26M |
| Shares Outstanding | 16.26M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 25.64% |
| Owned by Institutions (%) | n/a |
| Float | 12.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 8.64 |
| PS Ratio | 1.03 |
| PB Ratio | 1.44 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 3.71 |
| P/OCF Ratio | 3.67 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.88, with an EV/FCF ratio of 4.73.
| EV / Earnings | n/a |
| EV / Sales | 1.30 |
| EV / EBITDA | 3.88 |
| EV / EBIT | 26.73 |
| EV / FCF | 4.73 |
Financial Position
The company has a current ratio of 0.45, with a Debt / Equity ratio of 0.43.
| Current Ratio | 0.45 |
| Quick Ratio | 0.26 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | 0.92 |
| Debt / FCF | 1.12 |
| Interest Coverage | 1.60 |
Financial Efficiency
Return on equity (ROE) is -42.78% and return on invested capital (ROIC) is 2.30%.
| Return on Equity (ROE) | -42.78% |
| Return on Assets (ROA) | 1.83% |
| Return on Invested Capital (ROIC) | 2.30% |
| Return on Capital Employed (ROCE) | 4.66% |
| Weighted Average Cost of Capital (WACC) | 7.29% |
| Revenue Per Employee | 4.65M |
| Profits Per Employee | -2.79M |
| Employee Count | 33 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Physitrack has paid 1.02 million in taxes.
| Income Tax | 1.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -41.40% in the last 52 weeks. The beta is 0.53, so Physitrack's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -41.40% |
| 50-Day Moving Average | 8.72 |
| 200-Day Moving Average | 9.16 |
| Relative Strength Index (RSI) | 72.74 |
| Average Volume (20 Days) | 21,646 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Physitrack had revenue of SEK 153.55 million and -92.08 million in losses. Loss per share was -5.66.
| Revenue | 153.55M |
| Gross Profit | 97.07M |
| Operating Income | 7.49M |
| Pretax Income | -65.76M |
| Net Income | -92.08M |
| EBITDA | 51.56M |
| EBIT | 7.49M |
| Loss Per Share | -5.66 |
Balance Sheet
The company has 4.40 million in cash and 47.27 million in debt, with a net cash position of -42.88 million or -2.64 per share.
| Cash & Cash Equivalents | 4.40M |
| Total Debt | 47.27M |
| Net Cash | -42.88M |
| Net Cash Per Share | -2.64 |
| Equity (Book Value) | 109.37M |
| Book Value Per Share | 6.73 |
| Working Capital | -24.82M |
Cash Flow
In the last 12 months, operating cash flow was 42.87 million and capital expenditures -498,165, giving a free cash flow of 42.38 million.
| Operating Cash Flow | 42.87M |
| Capital Expenditures | -498,165 |
| Depreciation & Amortization | 44.49M |
| Net Borrowing | -742,440 |
| Free Cash Flow | 42.38M |
| FCF Per Share | 2.61 |
Margins
Gross margin is 63.22%, with operating and profit margins of 4.88% and -59.97%.
| Gross Margin | 63.22% |
| Operating Margin | 4.88% |
| Pretax Margin | -42.83% |
| Profit Margin | -59.97% |
| EBITDA Margin | 33.58% |
| EBIT Margin | 4.88% |
| FCF Margin | 27.33% |
Dividends & Yields
Physitrack does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -58.50% |
| FCF Yield | 26.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Physitrack has an Altman Z-Score of 0.97 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.97 |
| Piotroski F-Score | 5 |